Search

Your search keyword '"Kalçık, Macit"' showing total 573 results
Start Over Author "Kalçık, Macit"
573 results on '"Kalçık, Macit"'

1. Combination anticoagulation strategy in pregnancy with mechanical valves: The KYBELE study

Author

Özkan, Mehmet, Güner, Ahmet, Gündüz, Sabahattin, Yıldız, Gazi, Yıldırım, Ayşe İnci, Kalçık, Macit, Yesin, Mahmut, Bayam, Emrah, Kalkan, Semih, Gürsoy, Mustafa Ozan, Kılıçgedik, Alev, Bayram, Zübeyde, Sarı, Münevver, Aytürk, Mehmet, Karakoyun, Süleyman, Astarcıoğlu, Mehmet Ali, Gündoğdu, Elif Cansu, Biçer, Asuman, Gürcü, Emre, Koçak, Tuncer, and Demirbağ, Recep

Published
2024
Full Text
View/download PDF

4. Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry

Author

Kayıkcioglu, Meral, Başaran, Özcan, Doğan, Volkan, Mert, Kadir Uğur, Mert, Gurbet Özge, Özdemir, İbrahim Halil, Rencüzoğulları, İbrahim, Karadeniz, Fatma Özpamuk, Tekinalp, Mehmet, Aşkın, Lütfü, Demirelli, Selami, Gencer, Erkan, Bekar, Lütfü, Aktaş, Müjdat, Resulzade, Mübariz Murat, Kalçık, Macit, Aksan, Gökhan, Cinier, Göksel, Akay, Kadriye Halli, Pekel, Nihat, Utku Şenol, Demir, Vahit, İnci, Sinan, Derviş, Emir, Özlek, Bülent, Özlek, Eda, Çelik, Oğuzhan, Çil, Cem, and Biteker, Murat

Published
2023
Full Text
View/download PDF

5. Thrombolysis or Surgery in Patients With Obstructive Mechanical Valve Thrombosis: The Multicenter HATTUSHA Study

Author

Özkan, Mehmet, Gündüz, Sabahattin, Güner, Ahmet, Kalçık, Macit, Gürsoy, Mustafa Ozan, Uygur, Begüm, Keleş, Nurşen, Kaya, Hasan, Kılıçgedik, Alev, Bayam, Emrah, Kalkan, Semih, Astarcıoğlu, Mehmet Ali, Karakoyun, Süleyman, Yesin, Mahmut, İnan, Duygu, Fedakar, Ali, Sarıkaya, Sabit, Aksüt, Mehmet, Onan, Burak, and Koçoğulları, Cevdet Uğur

Published
2022
Full Text
View/download PDF

13. Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from RAMSES study

Author

Beton, Osman, Tekinalp, Mehmet, Aykan, Ahmet Çağrı, Kalaycıoğlu, Ezgi, Bolat, Ismail, Taşar, Onur, Şafak, Özgen, Kalçık, Macit, Yaman, Mehmet, İnci, Sinan, Altıntaş, Bernas, Kalkan, Sedat, Çalık, Feyza, Karaca, Oğuz, Helvacı, Füsun, Akay, Kadriye, Çanga, Yiğit, Çelebi, Savaş, Altuntas, Emine, Aytürk, Mehmet, Güneş, Hacı Murat, Bezgin, Tahir, Aksakal, Aytekin, Çakal, Beytullah, Çolak, Ayşe, Kaplan, Özgür, Tatlısu, Adem, Gözübüyük, Gökhan, Demirelli, Selami, Kaya, Adnan, Rencüzoğulları, İbrahim, Bayram, Zübeyde, Şimşek, Zeki, Civan, Murat, Batgharel, Ulaankhu, Ata, Ali Ekber, Göl, Gökhan, Mert, Gurbet Özge, Mert, Kadir Ugur, Değirmencioğlu, Aleks, Candan, Özkan, Çelebi, Özlem Özcan, Doğan, Cem, Yavuz, Fethi, Ulucan, Şeref, Arısoy, Arif, Şahin, Bingül Dilekçi, Ermiş, Emrah, Gökaslan, Serkan, Pektaş, İdris, Tanındı, Aslı, Tekin, Kamuran, Sancar, Kadriye Memic, Çekiç, Edip Güvenç, Başaran, Nesrin Filiz, Altun, Ibrahim, Başaran, Özcan, Dogan, Volkan, Biteker, Murat, Karadeniz, Fatma Özpamuk, Tekkesin, Ahmet İlker, Çakıllı, Yasin, Türkkan, Ceyhan, Hamidi, Mehmet, Demir, Vahit, Gürsoy, Mustafa Ozan, Öztürk, Müjgan Tek, Aksan, Gökhan, Seyis, Sabri, Ballı, Mehmet, Alıcı, Mehmet Hayri, Bozyel, Serdar, and Kırma, Cevat

Published
2017
Full Text
View/download PDF

14. A Comprehensive Evaluation of Abstracts from National Cardiology Congresses Based on the 2016 Academic Criteria.

Author

Güner, Ahmet, Güner, Ezgi Gültekin, Kalçık, Macit, Akman, Cemalettin, Kahraman, Serkan, Bayam, Emrah, Kalkan, Semih, Yesin, Mahmut, Çiloğlu, Koray, Gökçe, Kaan, Uzun, Fatih, Doğan, Abdullah, Gürsoy, Mustafa Ozan, Ertürk, Mehmet, Gündüz, Sabahattin, and Özkan, Mehmet

Abstract

Copyright of Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

18. Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study

Author

Başaran, Özcan, Dogan, Volkan, Beton, Osman, Tekinalp, Mehmet, Aykan, Ahmet Çağrı, Kalaycıoğlu, Ezgi, Bolat, Ismail, Taşar, Onur, Şafak, Özgen, Kalçık, Macit, Yaman, Mehmet, İnci, Sinan, Altıntaş, Bernas, Kalkan, Sedat, Kırma, Cevat, Biteker, Murat, Karadeniz, Fatma Özpamuk, Tekkesin, Ahmet İlker, Çakıllı, Yasin, Türkkan, Ceyhan, Hamidi, Mehmet, Demir, Vahit, Gürsoy, Mustafa Ozan, Öztürk, Müjgan Tek, Aksan, Gökhan, Seyis, Sabri, Ballı, Mehmet, Alıcı, Mehmet Hayri, Bozyel, Serdar, Altun, Ibrahim, Çalık, Feyza, Karaca, Oğuz, Helvacı, Füsun, Akay, Kadriye, Çanga, Yiğit, Çelebi, Savaş, Altuntas, Emine, Aytürk, Mehmet, Güneş, Hacı Murat, Bezgin, Tahir, Aksakal, Aytekin, Çakal, Beytullah, Çolak, Ayşe, Kaplan, Özgür, Tatlısu, Adem, Gözübüyük, Gökhan, Demirelli, Selami, Kaya, Adnan, Rencüzoğulları, İbrahim, Bayram, Zübeyde, Şimşek, Zeki, Civan, Murat, Batgharel, Ulaankhu, Ata, Ali Ekber, Göl, Gökhan, Mert, Gurbet Özge, Mert, Kadir Ugur, Değirmencioğlu, Aleks, Candan, Özkan, Çelebi, Özlem Özcan, Doğan, Cem, Yavuz, Fethi, Ulucan, Şeref, Arısoy, Arif, Şahin, Bingül Dilekçi, Ermiş, Emrah, Gökaslan, Serkan, Pektaş, İdris, Tanındı, Aslı, Tekin, Kamuran, Sancar, Kadriye Memic, Çekiç, Edip Güvenç, Başaran, Nesrin Filiz, and and Collaborators

Published
2017
Full Text
View/download PDF

22. Serum Levels of Cholesterol and Lipoproteins in Patients With Symptomatic Paravalvular Leaks

Author

Güner, Ahmet, primary, Özkan, Mehmet, additional, Kalçık, Macit, additional, Gürsoy, Mustafa Ozan, additional, Gündüz, Sabahattin, additional, Kılıçgedik, Alev, additional, Bayam, Emrah, additional, Kalkan, Semih, additional, Kırma, Cevat, additional, Türkmen, Muhsin, additional, Adademir, Taylan, additional, Aksüt, Mehmet, additional, Fedakar, Ali, additional, and Kırali, Kaan, additional

Published
2022
Full Text
View/download PDF

24. Relationship Between Systemic Inflammation Index and No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction.

Author

Çelik, Muhammet Cihat, Karayiğit, Orhan, Ozkan, Can, Dolu, Abdullah Kadir, and Kalçık, Macit

Subjects
PLATELET lymphocyte ratio, CONFIDENCE intervals, INFLAMMATION, MANN Whitney U Test, ST elevation myocardial infarction, NEUTROPHIL lymphocyte ratio, T-test (Statistics), BLOOD circulation, DESCRIPTIVE statistics, ODDS ratio, DATA analysis software, LOGISTIC regression analysis, RECEIVER operating characteristic curves
Abstract

This study aimed to evaluate the relationship between no-reflow phenomenon and systemic inflammation index (SII) and to compare the predictive capacity of SII together with the neutrophil–lymphocyte ratio (NLR), and the platelet–lymphocyte ratio (PLR) in patients with ST-elevation myocardial infarction (STEMI). A total of 785 patients were included. The thrombolysis in myocardial infarction (TIMI) flow degree has been used to describe the no-reflow phenomenon. The study population was divided into two groups regarding the presence of no-reflow phenomenon including 110 patients with no-reflow (TIMI frame count 0-2) and 675 patients without no-reflow (TIMI frame count 3). The NLR [6.6 (4.6-11.6) vs 3.2 (2.0-5.3); P <.001], PLR [175 (121.3-220) vs 102.6 (76.1-150.1); P <.001] and SII [1921(1225-2906) vs 738.5 (450.5-1293); P <.001] were significantly higher in the no-reflow group. High NLR (OR: 1.078, 95%CI: 1.027-1.397; P =.021), PLR (OR: 1.009, 95%CI: 1.003-1.021; P =.041) and SII (OR: 1.216, 95%CI: 1.106-1.942; P =.004) were found to be independently associated with no-reflow phenomenon. The comparison of the receiver-operating characteristic curves showed that area under the curve of SII was greater than that of NLR (.789 vs.766, P =.007) and PLR (.789 vs.759, P =.048). SII levels may predict no-reflow phenomenon better than NLR and PLR. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

27. How Did the Updated 2019 European Society of Cardiology/European Atherosclerosis Society Risk Categorization for Patients with Diabetes Affect the Risk Perception and Lipid Goals? A Simulated Analysis of Real-life Data from EPHESUS Study.

Author

Başaran, Özcan, Doğan, Volkan, Mert, Kadir Uğur, Özlek, Bülent, Özlek, Eda, Çelik, Oğuzhan, Çil, Cem, Özdemir, İbrahim Halil, Rencüzoğulları, İbrahim, Karadeniz, Fatma Özpamuk, Tekinalp, Mehmet, Aşkın, Lütfü, Demirelli, Selami, Gencer, Erkan, Bekar, Lütfü, Aktaş, Müjdat, Resulzade, Mübariz Murat, Kalçık, Macit, Aksan, Gökhan, and Çinier, Göksel

Subjects
RISK perception, LDL cholesterol, PEOPLE with diabetes, RISK society, ATHEROSCLEROSIS
Abstract

Background: The recent 2019 European Society of Cardiology/European Atherosclerosis Society practice guidelines introduced a new risk categorization for patients with diabetes. We aimed to compare the implications of the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society guidelines with regard to the lipid-lowering treatment use, low-density lipoprotein cholesterol goal attainment rates, and the estimated proportion of patients who would be at goal in an ideal setting. Methods: Patients with diabetes were classified into 4 risk categories according to 2019 European Society of Cardiology/European Atherosclerosis Society dyslipidemia guidelines from the database of EPHESUS (cross-sectional, observational, countrywide registry of cardiology outpatient clinics) study. The use of lipid-lowering treatment and low-density lipoprotein cholesterol goal attainment rates were then compared according to previous and new guidelines. Results: This analysis included a total of 873 diabetic adults. Half of the study population (53.8%) were on lipid-lowering treatment and almost one-fifth (19.1%) were on highintensity statins. While low-density lipoprotein cholesterol goal was achieved in 19.5% and 7.5% of patients, 87.4% and 69.6% would be on target if their lipid-lowering treatment was intensified according to 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society lipid guidelines, respectively. The new target <55 mg/dL could only be achieved in 2.2% and 8.1% of very high-risk primary prevention and secondary prevention patients, respectively. Conclusion: The control of dyslipidemia was extremely poor among patients with diabetes. The use of lipid-lowering treatment was not at the desired level, and high-intensity lipid-lowering treatment use was even lower. Our simulation model showed that the highdose statin plus ezetimibe therapy would improve goal attainment; however, it would not be possible to get goals with this treatment in more than one-third of the patients. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

28. Cardiovascular evaluation of pregnant women with hypertrophic cardiomyopathy

Author

Güner, Ahmet, primary, Candan, Özkan, additional, Kahraman, Serkan, additional, Güner, Ezgi Gültekin, additional, Özcan, Sevgi, additional, Gürsoy, Mustafa Ozan, additional, Kalçık, Macit, additional, Uslu, Abdulkadir, additional, Dönmez, Esra, additional, Zehir, Regayip, additional, Ertürk, Mehmet, additional, Yıldız, Mustafa, additional, and Özkan, Mehmet, additional

Published
2022
Full Text
View/download PDF

30. Gebelikte Kardiyovasküler Sistem Hastalıkları

Author

Şentürk, Metin, additional, Süzer Aslan, Melek, additional, Akça, Barış, additional, Çıplak, Barış, additional, Hidayet, Şıho, additional, Bayramoğlu, Adil, additional, Çakmak, Abdulkadir, additional, Pelit, Erdinç, additional, Yağmur, Aysel, additional, Seçici, Serkan, additional, Elçi, Mehmet Emre, additional, Kalçık, Macit, additional, and Güner, Ahmet, additional

Published
2022
Full Text
View/download PDF

33. The predictive value of CHADS2 score for subclinical cerebral ischemia after carotid artery stenting (from the PREVENT-CAS trial)

Author

Çelik, Ömer, Güner, Ahmet, Kalçık, Macit, Güler, Arda, Demir, Ali Riza, Demir, Yusuf, Ertürk, Mehmet, and Kalçık, Macit

Subjects
Interventional MRI, Stroke, Carotid Artery Disease, Intervention, Surgery, cardiovascular diseases, Carotid, Imaging
Abstract

Abstarct Background Carotid artery stenting (CAS) is being increasingly used as an alternative revascularization procedure to carotid endarterectomy; however, subclinical ischemic cerebral lesions after CAS remain as a matter of concern. Hence, we aimed to assess the clinical utility of the CHADS(2) score in predicting subclinical ischemic events after CAS. Methods We prospectively evaluated 107 patients (mean age: 70.4 +/- 6.6 years, male:77) who underwent CAS for carotid artery revascularization. The patients having symptomatic transient ischemic attack or stroke after CAS were excluded. The presence of new hyperintense lesion on diffusion-weighted imaging (DWI) without any neurological findings was considered as silent ischemia. Patients were classified into two groups as DWI-positive and DWI-negative patients. Results Among study population, 28 patients (26.2%) had subclinical embolism. The DWI-positive group had a significantly higher CHADS2 scores, older age, more frequent history of stroke, higher proportion of type III aortic arch, and longer fluoroscopy time than the DWI-negative group. Increased CHADS(2) score was identified as one of the independent predictors of silent embolism (OR = 5.584; 95%CI: 1.516-20.566; p = .010), and CHADS(2) score higher than 2.5 predicted subclinical cerebral ischemia with a sensitivity of 72% and a specificity of 71% (AUC: 0.793; 95% CI: 0.696 - 0.890; p < .001). Conclusions CHADS(2) score was able to predict the risk of periprocedural subclinical ischemic events in CAS and might be of clinical value in the management of patients with carotid artery stenosis. WOS:000581116800001 2-s2.0-85092394834 PubMed: 33085162

Published
2021

35. Diagnosis, treatment & management of prosthetic valve thrombosis: the key considerations

Author

Gündüz, Sabahattin, Kalçık, Macit, Gürsoy, Mustafa Ozan, Güner, Ahmet, Özkan, Mehmet, and Kalçık, Macit

Subjects
Valve, Echocardiography, Prosthesis, Thrombolysis, Pannus
Abstract

Introduction: Prosthetic heart valve thrombosis is a life-threatening complication after valve replacement surgery. Although subtherapeutic anticoagulation is the main cause, there are many other conventional and esoteric predisposing factors. Areas covered: The etiopathogenesis, diagnosis, and management of prosthetic heart valve thrombosis with particular focus on conventional and esoteric predisposing factors, diagnosis with multimodality imaging and current therapeutic approaches were covered. Expert opinion: Subtherapeutic anticoagulation remains the key driving force for the development of prosthetic valve thrombosis. However, cardiologists should be cognizant of other frequent or rare conventional and esoteric causes. The diagnosis is now more straightforward with the use of multimodality imaging. Transthoracic and transesophageal echocardiography with or without real-time three-dimensional imaging are the current gold standard modalities. Multidetector computed tomography is now a major complementary tool. The favorable clinical outcomes with recently introduced slow or ultra-slow infusions of alteplase, as compared to relatively poor surgical results, have rendered thrombolytic therapy the first-line treatment option in most eligible patients with prosthetic valve thrombosis. Surgical treatment could be reserved in whom thrombolytic therapy is contraindicated or has already failed. The efficacy and safety of thrombolytic therapy as compared to surgery should be confirmed with large observational cohorts, and ideally randomized trials. WOS:000518236300008 2-s2.0-85081244672 PubMed: 32085683

Published
2020

36. A comprehensive review of the diagnosis and management of mitral paravalvular leakage

Author

Gürsoy, Mustafa Ozan, Güner, Ahmet, Kalçık, Macit, Bayam, Emrah, Özkan, Mehmet, and Kalçık, Macit

Subjects
Transcatheter Closure, Cardiac Surgery, Echocardiography, Mitral Valve
Abstract

Mitral paravalvular leaks (PVLs) commonly occur in patients with prosthetic valves. Paravalvular defects may be clinically inconsequential and may aggravate hemolysis or cause heart failure through regurgitation. Accordingly, patients may eventually require intervention such as redo surgery or a transcatheter closure of the defects. The introduction of purpose-specific closure devices and new steerable catheters has opened a new frontier for the transcatheter PVL closure. This mode of treatment is an initial therapy in most centers with experienced structural heart team. However, head-to-head data comparing two treatment modalities (surgery and transcatheter closure) are limited, and the world-wide experience is based on nonrandomized studies. Multimodality imaging, including three-dimensional transesophageal echocardiography, facilitates the delineation of mitral PVLs and provides essential data that aids the communication between the members of the structural heart team. In the near future, the success of interventional therapies will most probably increase in patients with mitral PVLs with the introduction of hybrid imaging modalities (echocardiography, cardiac computed tomography, and fluoroscopy). In conclusion, this paper summarizes the etiopathogenesis, clinical characteristics, diagnosis, and treatment of mitral PVLs. WOS:000595157500005 2-s2.0-85097016592 PubMed: 33253127

Published
2020

37. The relationship between CHA2DS2VASc score and left ventricular apical thrombus formation in patients with acute anterior ST segment elevation myocardial infarction

Author

Bayam, Emrah, primary, Çakmak, Ender Özgün, additional, Yıldırım, Ersin, additional, Kalçık, Macit, additional, Bilen, Yusuf, additional, Güner, Ahmet, additional, Küp, Ayhan, additional, Kahyaoğlu, Muzaffer, additional, Çelik, Mehmet, additional, Öcal, Lütfi, additional, Avcı, Anıl, additional, and Zehir, Regayip, additional

Published
2021
Full Text
View/download PDF

41. Lessons Learned From Intermittent Dysfunction of Mechanical Heart Valve.

Author

Kalkan, Semih, Güner, Ahmet, Kalçık, Macit, Gürsoy, Mustafa Ozan, Gündüz, Sabahattin, Bayam, Emrah, Yesin, Mahmut, Karakoyun, Süleyman, Keten, Mustafa Ferhat, and Özkan, Mehmet

Subjects
PROSTHETIC heart valves, MITRAL valve, AORTIC valve transplantation, MITRAL valve prolapse, AORTIC valve insufficiency, MITRAL valve insufficiency, PATIENT decision making
Abstract

Background: Intermittent malfunction is a rare but potentially serious complication of prosthetic heart valve replacement. This study aimed to describe the clinical features and etiologic causes of patients with intermittent mechanical prosthetic heart valve dysfunction. Methods: Between 2010 and 2021, 16 patients who were evaluated in the echocardiography laboratory of Koşuyolu Training and Research Hospital with the diagnosis of intermittent malfunction of prosthetic valves were included in the study. Results: The evaluated patients consisted of 12 bi-leaflet mitral valve replacements and 2 mono-leaflet mitral valve replacements. The underlying causes of intermittent malfunction were classified as follows: residual chord (n = 4), obstructive thrombus (n = 2), non-obstructive thrombus (n = 2), vegetation (n = 2), pannus and obstructive thrombus coexistence (n = 1), and solely pannus (n = 1). One of the patients with mono-leaflet mitral valve replacements had pannus and obstructive thrombus. In the other patient with mono-leaflet mitral valve replacement, a stuck valve was observed in 1 of 12 beats secondary to arrhythmia. There were also 2 patients with aortic valve replacements. One patient had moderate aortic regurgitation due to prominent calcification and the other had moderate obstruction due to pannus. In the patient with pannus, a stuck leaflet was observed in 1 of 6 beats and moderate aortic regurgitation arose in 1 of 2 beats in the patient with calcification. Conclusions: The intermittent stuck valve may have catastrophic outcomes. When making a treatment decision in these patients, assessing the degree of regurgitation or stenosis is essential. In particular, the frequency of entrapment should be taken into consideration when deciding the optimal therapy for intermittent prosthetic heart valve dysfunction. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

45. Identification of mechanical prosthetic heart valves based on distinctive cinefluoroscopic and echocardiographic markers

Author

Kalçık, Macit, Güner, Ahmet, Yesin, Mahmut, Bayam, Emrah, Kalkan, Semih, Gündüz, Sabahattin, Özkan, Mehmet, and Kalçık, Macit

Subjects
Heart Valve, Mechanical Prosthesis, Echocardiography, Transesophageal Echocardiography, Cinefluoroscopy
Abstract

The past 65 years have witnessed remarkable progress in the development of safe, hemodynamically favorable mechanical heart valves. Today, there are a large number and variety of prostheses in use and many prostheses have been used for a while and then discontinued. When patients lack reliable information about their heart valve prostheses, identification of valve model becomes difficult even for specialized physicians in this area. A combination of cinefluoroscopy and echocardiography makes it possible to provide accurate and detailed information regarding identification of prosthetic valve models. Fluoroscopic examination is a useful technique to evaluate patients following mechanical heart valve replacement. However, transthoracic echocardiography and transesophageal echocardiography have almost replaced cinefluoroscopy in the evaluation of prosthetic heart valves. Especially, real-time three-dimensional transesophageal echocardiography provides distinctive images of prosthetic heart valves, particularly for those in the mitral position. A large body of literature has been published to familiarize physicians with the radiological appearance of numerous mechanical prostheses. However, there is a lack of data regarding the identification of prosthetic valve models based on echocardiographic appearance. In this review, we aimed to describe distinctive echocardiographic and cinefluoroscopic markers for identifying the type and brand of several commonly used mechanical prosthetic heart valves. WOS:000476452100001 2-s2.0-85068593264 PubMed: 31269859

Published
2019

46. Sequential combination of different thrombolytic therapy regimens in the management of patients with prosthetic valve thrombosis and stuck valves

Author

Kalçık, Macit, Güner, Ahmet, Bayam, Emrah, Kalkan, Semih, Yesin, M., Gürsoy, Mustafa Ozan, Özkan, Mehmet, and Kalçık, Macit

Abstract

Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology -- AUG 31-SEP 04, 2019 -- Paris, FRANCE [Abstract Not Available] European Soc Cardiol WOS:000507313003748

Published
2019

48. The effect of complex vascular anatomy on silent new ischemic cerebral lesions in carotid artery stenting procedures (from the COMPLEX-CAS Trial)

Author

Güner, Ahmet, primary, Çelik, Ömer, additional, Topel, Çağdaş, additional, Arif Yalçın, Ahmet, additional, Kalçık, Macit, additional, Uzun, Fatih, additional, Altunova, Mehmet, additional, Örten, Murat, additional, Akman, Cemalettin, additional, Güner, Ezgi Gültekin, additional, and Ertürk, Mehmet, additional

Published
2021
Full Text
View/download PDF

49. The relationship between dual antiplatelet treatment (DAPT) score and saphenous venous grafts patency after coronary artery bypass grafting surgery

Author

Bayam, Emrah, primary, Öztürkeri, Burak, additional, Yıldırım, Ersin, additional, Kalçık, Macit, additional, Küp, Ayhan, additional, Çakmak, Ender Özgün, additional, Günay, Nuran, additional, Güner, Ahmet, additional, Kalkan, Semih, additional, Karaduman, Ahmet, additional, Kahyaoğlu, Muzaffer, additional, and Zehir, Regayip, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results